Sustainability Report

Overview

The report describes Sun Pharma's FY21 sustainability performance across economic, environmental and social topics under a GRI Core approach. It highlights consolidated revenue of ₹334,981 Million, 37,000+ global employees, and ~38% renewable energy. Environmental disclosures include 3,158,195 GJ of total energy consumption, 3007 tCO2 of Scope 3 emissions, and 2,258,504 KL of water consumed. DNV provided limited assurance over the sustainability disclosures for the India reporting boundary.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 April 2020 – 31 March 2021
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services